PRGO

Perrigo Company PLC

Add to Watchlist

Advanced Chart

22.550

-0.28(-1.226%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

23.050

Open

22.830

VWAP

22.67

Vol

3.36M

Mkt Cap

3.10B

Low

22.330

Amount

76.23M

EV/EBITDA(TTM)

8.49

Total Shares

137.58M

6.30B

EV/OCF(TTM)

17.20

P/S(TTM)

0.72

Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

1.08B

+3.84%

0.700

+16.67%

1.18B

+3.99%

1.045

+12.36%

1.10B

+1.25%

0.774

-4.46%

Estimates Revision

The market is revising Upward the revenue expectations for Perrigo Company plc (PRGO) for FY2025, with the revenue forecasts being adjusted by 0.16% over the past three months. During the same period, the stock price has changed by -16.45%.

Revenue Estimates for FY2025

Revise Upward

+0.16%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+0.57%

In Past 3 Month

Stock Price

Go Down

-16.45%

In Past 3 Month

2 Analyst Rating

59.65% Upside

Wall Street analysts forecast PRGO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRGO is 36.00 USD with a low forecast of 30.00 USD and a high forecast of 42.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

1 Hold

0 Sell

Moderate Buy

59.65% Upside

Current: 22.550

Low

30.00

Averages

36.00

High

42.00

59.65% Upside

Current: 22.550

Low

30.00

Averages

36.00

High

42.00

Canaccord

Susan Anderson

Buy

downgrade

$42 -> $40

2025-08-07

New

Reason

Canaccord

Susan Anderson

Price Target

$42 -> $40

2025-08-07

New

downgrade

Buy

Reason

Canaccord analyst Susan Anderson lowered the firm's price target on Perrigo to $40 from $42 and keeps a Buy rating on the shares. The firm updated its model following Q2 results where sales were down but management reiterated both top and bottom-line expectations which are achievable given the company's limited tariff exposure, opportunity to benefit from trade down, new contract wins in PL OTC, and continued strong European business.

Piper Sandler

Korinne Wolfmeyer

Buy

Hold

Downgrades

$34 → $27

2025-01-06

Reason

Piper Sandler

Korinne Wolfmeyer

Price Target

$34 → $27

2025-01-06

Downgrades

Buy

Hold

Reason

Piper Sandler downgraded Perrigo to Neutral from Overweight with a price target of $27, down from $34.

Canaccord Genuity

Susan Anderson

Strong Buy

Maintains

$42

2024-09-30

Reason

Canaccord Genuity

Susan Anderson

Price Target

$42

2024-09-30

Maintains

Strong Buy

Reason

Jefferies

Keith Devas

Strong Buy

Hold

Downgrades

$50 → $30

2024-09-23

Reason

Jefferies

Keith Devas

Price Target

$50 → $30

2024-09-23

Downgrades

Strong Buy

Hold

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Perrigo Company PLC (PRGO.N) is 7.21, compared to its 5-year average forward P/E of 12.96. For a more detailed relative valuation and DCF analysis to assess Perrigo Company PLC 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued

5Y Average PE

12.96

Current PE

7.21

Overvalued PE

16.76

Undervalued PE

9.16

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued

5Y Average EV/EBITDA

11.09

Current EV/EBITDA

8.28

Overvalued EV/EBITDA

12.94

Undervalued EV/EBITDA

9.24

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

1.05

Current PS

0.71

Overvalued PS

1.28

Undervalued PS

0.83